Moberg Derma is developing innovative medical products based on substances with well established use. Products are based on patented drug delivery technology or new combinations of substances.

Product Indication Status
Emtrix™ 
Treatment of discoloured and deformed nails resulting from infection, trauma or psoriasis
CE-mark, launch 2010 in first markets
Kaprolac® Product Range
Conditions associated with dry and scaly skin 
 CE-mark/Cosmeceuticals, launch 2010 in first markets
A-Fizz™ Anal Fissures Preclinical development
Limtop Actinic Keratosis Preclinical development
MOB-015 Confidential Preclinical development
 

 

Moberg Derma AB
Gunnar Asplunds Allé 32, Hus D,  171 63 Solna, Sweden
Phone: +46 8 522 30 700
info@mobergderma.se